The United States remains the global epicentre for clinical research, accounting for over 40% of the world's clinical trials. In this highly regulated and data-intensive environment, Electronic Clinical Outcome Assessment (eCOA) systems have evolved from a "nice-to-have" to a fundamental requirement. Our role as a leading manufacturer is to bridge the gap between advanced hardware manufacturing and the stringent requirements of the FDA 21 CFR Part 11 and HIPAA regulations.
In the post-pandemic era, US-based Clinical Research Organizations (CROs) and pharmaceutical giants are increasingly adopting decentralized or hybrid trial models. This shift demands eCOA systems that are not only portable and rugged but also seamlessly integrated with cloud-based data management. Our HS-series devices are designed specifically to support remote participant monitoring, ensuring high data integrity (ALCOA+ principles) while reducing patient burden in diverse geographic locations across the US, from urban hubs to rural communities.
For an eCOA system to be viable in the United States, it must navigate a complex web of regulatory and logistical hurdles. Our manufacturing process incorporates:
Dongguan Trial Medical Co., Ltd. represents the pinnacle of specialized medical device manufacturing. Based in the global tech hub of Dongguan, China, we leverage a world-class electronics ecosystem to provide US clients with high-precision eCOA hardware at a competitive scale. Our 11,000 square meter facility is optimized for the rigorous quality standards required by North American procurement teams.
By combining China’s manufacturing agility with American-standard quality control, we offer OEM and ODM services that allow US clinical tech providers to white-label sophisticated assessment tools, such as our Cobb Angle Ultrasound Scanners or Neurorehabilitation scales, reducing their time-to-market significantly.
Establishment: 2016 in Dongguan, China.
Infrastructure: 11,000+ SQM Modern Facility.
Human Capital: 230+ Professionals, including a dedicated R&D division for AI-integrated diagnostics.
Core Focus: Remote clinical trial monitoring, wearable health data collection, and patient-centric trial models.
Utilizing our CE-certified traction assessment systems in private US physical therapy clinics to track patient recovery progress with quantifiable data.
Deploying our digital mental health screening platforms in outpatient clinics for rapid, automated psychological evaluation and risk assessment.
Integrating automatic electronic tourniquet systems and ultrasound imaging scanners in surgical suites for enhanced intraoperative monitoring.
Applying integrated digital diagnosis systems for longitudinal clinical studies in American dental schools and research institutes.
Modern global enterprises, particularly those operating across the US and Europe, require a manufacturer that understands Environmental, Social, and Governance (ESG) reporting. Trial Medical provides comprehensive ESG reports and Model 123 quality assurance inspections to meet the compliance audits of Fortune 500 pharmaceutical companies. Our IQAS Medical Device Quality Assurance system ensures that every unit shipped to the United States meets the rigorous reliability benchmarks expected of critical clinical infrastructure.
Trusted by over 100 Clinical Research Organizations in North America.
Send Inquiry Now
Trial Medical
